Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients
- PMID: 34456266
- PMCID: PMC8612847
- DOI: 10.1097/TP.0000000000003942
Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients
Conflict of interest statement
The authors declare no funding and conflicts of interest.
Comment on
-
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.Transplantation. 2021 Nov 1;105(11):e265-e266. doi: 10.1097/TP.0000000000003907. Transplantation. 2021. PMID: 34310531 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous